Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Cash from Financing Activities (2016 - 2026)

Insight Molecular Diagnostics' Cash from Financing Activities history spans 6 years, with the latest figure at -$252000.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 102.33% to -$252000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $28.1 million, a 37.41% increase, with the full-year FY2025 number at $28.1 million, up 37.41% from a year prior.
  • Cash from Financing Activities hit -$252000.0 in Q4 2025 for Insight Molecular Diagnostics, down from -$120000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for IMDX hit a ceiling of $69.9 million in Q1 2021 and a floor of -$528000.0 in Q3 2022.
  • Historically, Cash from Financing Activities has averaged $9.2 million across 5 years, with a median of -$30000.0 in 2023.
  • The widest YoY moves for Cash from Financing Activities: up 36223.33% in 2024, down 750.0% in 2024.
  • Tracing IMDX's Cash from Financing Activities over 5 years: stood at -$269000.0 in 2021, then skyrocketed by 62.83% to -$100000.0 in 2022, then skyrocketed by 70.0% to -$30000.0 in 2023, then surged by 36223.33% to $10.8 million in 2024, then tumbled by 102.33% to -$252000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for IMDX at -$252000.0 in Q4 2025, -$120000.0 in Q3 2025, and -$114000.0 in Q2 2025.